M42, Juvenescence partner to develop AI-powered therapeutics
A new collaboration will combine genomics capabilities with AI to develop innovative therapeutics that target the underlying causes of age-related…
A new collaboration will combine genomics capabilities with AI to develop innovative therapeutics that target the underlying causes of age-related…